Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shuntaro Tokunaga"'
Autor:
Eiji Iwata, Teruaki Nishiuma, Suya Hori, Keiko Sugiura, Masato Taki, Shuntaro Tokunaga, Junya Kusumoto, Takumi Hasegawa, Akira Tachibana, Masaya Akashi
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282191 (2023)
BackgroundEmpyema is a life-threatening infection often caused by oral microbiota. To the best of our knowledge, no reports have investigated the association between the objective assessment of oral health and prognosis in patients with empyema.Mater
Externí odkaz:
https://doaj.org/article/ba5a0c20653b40228eec657dc0f6d841
Autor:
Motoko Tachihara, Ryota Dokuni, Keiko Okuno, Shuntaro Tokunaga, Kyosuke Nakata, Naoko Katsurada, Masatsugu Yamamoto, Tatsuya Nagano, Kazuyuki Kobayashi, Yugo Tanaka, Yasuhiro Funada, Yoshimasa Maniwa, Yoshihiro Nishimura
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2536-2541 (2020)
Background Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events
Externí odkaz:
https://doaj.org/article/e26a710639fb4bffb215797509ffae2d
Autor:
Shuntaro Tokunaga, Tatsuya Nagano, Yugo Tanaka, Yoshimasa Maniwa, Ryota Dokuni, Kazuyuki Kobayashi, Kyosuke Nakata, Motoko Tachihara, Naoko Katsurada, Yasuhiro Funada, Yoshihiro Nishimura, Keiko Okuno, Masatsugu Yamamoto
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 9, Pp 2536-2541 (2020)
Thoracic Cancer, Vol 11, Iss 9, Pp 2536-2541 (2020)
Background Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events
Autor:
Kazuyuki Kobayashi, Masako Yumura, Naoko Katsurada, Masatsugu Yamamoto, Shuntaro Tokunaga, Hiroshi Kamiryo, Yoshihiro Nishimura, Kiyoko Koyama, Tatsunori Kiriu, Yoshimasa Maniwa, Daisuke Tamura, Yukihisa Hatakeyama, Ryota Dokuni, Yugo Tanaka, Daisuke Hazama, Motoko Tachihara, Kyosuke Nakata
Publikováno v:
Cancer Management and Research. 12:777-782
Purpose Adjuvant chemotherapy with cisplatin (CDDP) plus vinorelbine is the standard regimen for the treatment of non-small cell lung cancer (NSCLC). However, CDDP elicits severe toxic effects, including emesis, neurotoxicity, and renal damage; carbo
Autor:
Miyako Satouchi, Tatsunori Kiriu, Ryota Dokuni, Yoshihiro Nishimura, Motoko Tachihara, Masatsugu Yamamoto, Yohei Shimono, Shuntaro Tokunaga, Daisuke Tamura, Kei Kunimasa, Tatsuya Nagano, Kazuyuki Kobayashi
Publikováno v:
Cancer Science
In pathway-targeted cancer drug therapies, the relatively rapid emergence of drug-tolerant persisters (DTPs) substantially limits the overall therapeutic benefit. However, little is known about the roles of DTPs in drug resistance. In this study, we
Autor:
Kyosuke Nakata, Hiroshi Kamiryo, Yoshihiro Nishimura, Motoko Tachihara, Yasuhiro Sakai, Daisuke Tamura, Kei Kunimasa, Nobuko Hazeki, Shuntaro Tokunaga, Kazuyuki Kobayashi
Publikováno v:
Respirology. 21:1100-1105
Background and objective Endobronchial ultrasonography with a guide sheath transbronchial biopsy (EBUS-GS TBB) has been used to diagnose peripheral pulmonary lesions (PPLs). In this study, we evaluated the diagnostic utility of conventional TBB after
Autor:
Motoko, Tachihara, Daisuke, Tamura, Tatsunori, Kiriu, Shuntaro, Tokunaga, Yukihisa, Hatakeyama, Haruko, Shinke, Tatsuya, Nagano, Kyosuke, Nakata, Nobuko, Hazeki, Hiroshi, Kamiryo, Kazuyuki, Kobayashi, Yoshihiro, Nishimura
Publikováno v:
The Kobe journal of medical sciences. 63(4)
Endobronchial ultrasonography and guide sheath (EBUS-GS) technique has high diagnostic yield in lung nodules. Virtual bronchoscopic navigation (VBN) can lead bronchoscope to the target bronchi. The aim of this prospective study was to compare the dia
Autor:
Motoko Tachihara, Hiroshi Yokozaki, Yoshihiro Nishimura, Hiroshi Kamiryo, Kyosuke Nakata, Masahiro Katsurada, Tatsuya Nagano, Shuntaro Tokunaga, Kazuyuki Kobayashi, Masatsugu Yamamoto
Publikováno v:
Anticancer research. 37(5)
Background/aim Amrubicin (AMR) has shown promising activity for lung cancer. However, little is known about the mechanism underlying resistance to this agent. The aim of this study was to elucidate the mechanism underlying resistance to AMR. Material
Autor:
Kazuyuki Kobayashi, Shuntaro Tokunaga, Motoko Tachihara, Yasuhiro Funada, Yoshihiro Nishimura, Daisuke Tamura
Publikováno v:
Haigan. 54:978-982
Autor:
Kazuyuki Kobayashi, Yoshimasa Maniwa, Yasuhiro Funada, Yoshihiro Nishimura, Masatsugu Yamamoto, Motoko Tachihara, Shuntaro Tokunaga, K. Okuno, Ryota Dokuni, Yugo Tanaka
Publikováno v:
Journal of Thoracic Oncology. 13:S57-S58